2.
两组患者促排卵结局比较
Controlled ovarian hyperstimulation outcomes of the patients in cetrorelix and ganirelix groups (Mean±SD or percentages)
| Index | Cetrorelix group | Ganirelix group | P | Adjusted P value |
| No. of cycles | 1368 | 1204 | - | - |
| Dosage of Gn used (U) | 2342.36±892.01 | 2452.50±847.34 | 0.001 | 0.060 |
| Value of FSH on hCG trigger day (U/L) | 20.03±8.89 | 19.93±9.02 | 0.861 | 0.706 |
| Value of LH on hCG trigger day (U/L) | 3.44±4.58 | 3.53±3.58 | 0.570 | 0.144 |
| Value of E2 on hCG trigger day (ng/L) | 2483.81±1937.75 | 2390.40±1706.49 | 0.197 | 0.724 |
| Value of P on hCG trigger day (μg/L) | 1.01±0.71 | 0.98±0.91 | 0.377 | 0.481 |
| Proportion of LH > 10 U/L on hCG trigger day | 3.7%(51/1368) | 3.2%(38/1204) | 0.428 | 0.963 |
| Spontaneous ovulation rate | 0.6%(8/1368) | 0.5%(6/1204) | 0.766 | 0.879 |
| No. of oocytes retrieved | 11.04±7.55 | 10.63±7.38 | 0.168 | 0.758 |
| Moderate/severe OHSS rate | 0.1%(1/1368) | 0.7%(9/1204) | 0.008 | 0.006 |
| No. of embryos available | 4.25±3.41 | 4.01±3.42 | 0.077 | 0.566 |
| No. of high quality embryos | 2.77±2.77 | 2.62±2.69 | 0.162 | 0.390 |